VEGFA and age-related macular degeneration: Importantly, our results suggest that MMP-9 and VEGF is one of the noteworthy therapeutic targets of EGCG for treatment and prevention of ocular angiogenic diseases, such as age-related macular degeneration, diabetic retinopathy, and corneal neovascularization.